Journal articleJ Am Heart Assoc · June 2, 2026
BACKGROUND: The American Heart Association Predicting Risk of Cardiovascular Disease Events risk scores estimate cardiovascular disease (CVD) risk, including heart failure (HF) and atherosclerotic CVD (ASCVD) events. Whether they associate with subclinical ...
Full textLink to itemCite
Journal articleStroke · June 2026
BACKGROUND: Stroke is a possible complication after bioprosthetic aortic valve replacement (AVR) for severe aortic stenosis (AS), impacting morbidity and mortality. Accurate estimates of the proportion of individuals who experience stroke within and beyond ...
Full textLink to itemCite
Journal articleJACC Adv · June 2026
Genetic testing is increasingly common for people with cardiomyopathies and arrhythmias, with cascade screening recommended for first-degree relatives of those carrying pathogenic or likely pathogenic variants. Consequently, a growing number of women of ch ...
Full textLink to itemCite
Journal articleCirc Cardiovasc Imaging · June 2026
BACKGROUND: The 2016 American Society of Echocardiography (ASE) guidelines for left ventricular diastolic dysfunction (LVDD) classification resulted in a significant proportion of indeterminate classifications and grades. To address these limitations and i ...
Full textLink to itemCite
Journal articleHypertension · February 2026
BACKGROUND: Timely diagnosis of hypertension provides an opportunity for cardiovascular disease prevention after a hypertensive disorder of pregnancy. We assessed the association between blood pressure 15 to 90 days postpartum and incident hypertension aft ...
Full textLink to itemCite
Journal articleJ Womens Health (Larchmt) · January 2026
BACKGROUND: Hypertensive disorders of pregnancy (HDP) are a spectrum of disorders with increasing severity: gestational hypertension, preeclampsia, preexisting hypertension with preeclampsia, and severe preeclampsia/eclampsia. Factors associated with devel ...
Full textLink to itemCite
Journal articleJACC Adv · January 2026
BACKGROUND: Few studies have evaluated the prevalence or severity of mitral valve prolapse (MVP) and other valvular heart disease (VHD) in the rural U.S. South, where strategies for early detection are crucial for risk stratification and prevention. OBJECT ...
Full textLink to itemCite
Journal articleJACC Basic Transl Sci · October 2025
Coronary artery bypass graft (CABG) uses the patient's internal mammary artery and saphenous vein; however, unavailable or poor quality autologous vessels limit revascularization. This study addresses the critical need for alternative CABG conduits by eval ...
Full textLink to itemCite
Journal articleCirc Cardiovasc Interv · August 2025
BACKGROUND: There is heterogeneity in coronary artery disease (CAD) severity among individuals with severe aortic stenosis (AS), but whether this differentially influences prognosis is unknown. METHODS: Patients with severe AS in the PARTNER 1, 2, and 3 tr ...
Full textLink to itemCite
Journal articleJACC Cardiovasc Imaging · April 2025
BACKGROUND: Implementation of semaglutide weight loss therapy has been challenging due to drug supply and cost, underscoring a need to identify those who derive the greatest absolute benefit. OBJECTIVES: Allocation of semaglutide was modeled according to c ...
Full textLink to itemCite
Journal articleCirc Cardiovasc Imaging · February 2025
BACKGROUND: Patients with abnormal (positive) exercise electrocardiography, but normal stress echocardiography (+ECG/-Echo), have an increased risk of adverse cardiovascular events compared with patients with a normal (negative) ECG and a normal stress Ech ...
Full textLink to itemCite
Journal articleJ Card Fail · November 2024
BACKGROUND: Data collected via wearables may complement in-clinic assessments to monitor subclinical heart failure (HF). OBJECTIVES: Evaluate the association of sensor-based digital walking measures with HF stage and characterize their correlation with in- ...
Full textLink to itemCite
Journal articleAm Heart J · July 2024
BACKGROUND: Hypertensive disorders of pregnancy (HDP), including gestational hypertension, preeclampsia, and eclampsia, are risk factors for cardiovascular (CV) disease. Guidelines recommend that women with HDP be screened for the development of hypertensi ...
Full textLink to itemCite
Journal articlePsychiatry Res · March 2024
The Patient Health Questionnaire 9 (PHQ-9) is the current standard outpatient screening tool for measuring and tracking the nine symptoms of major depressive disorder (MDD). While the PHQ-9 was originally conceptualized as a unidimensional measure, it has ...
Full textOpen AccessLink to itemCite
Journal articleMed Phys · March 2024
BACKGROUND: As a leading cause of death, worldwide, cardiovascular disease is of great clinical importance. Among cardiovascular diseases, coronary artery disease (CAD) is a key contributor, and it is the attributed cause of death for 10% of all deaths ann ...
Full textLink to itemCite
Journal articleJACC Adv · March 2024
BACKGROUND: Low stroke volume index <35 ml/m2 despite preserved ejection fraction (paradoxical low flow [PLF]) is associated with adverse outcomes in patients with aortic stenosis undergoing transcatheter aortic valve replacement (TAVR) or surgical aortic ...
Full textLink to itemCite
Journal articleCirc Cardiovasc Imaging · February 2024
Innovations in cardiac imaging have fundamentally advanced the understanding and treatment of cardiovascular disease. These advances in noninvasive cardiac imaging have also expanded the role of the cardiac imager and dramatically increased the demand for ...
Full textLink to itemCite
Journal articleCirc Cardiovasc Imaging · February 2024
Achieving optimal cardiovascular health in rural populations can be challenging for several reasons including decreased access to care with limited availability of imaging modalities, specialist physicians, and other important health care team members. The ...
Full textLink to itemCite
Journal articleJ Card Fail · November 2023
BACKGROUND: Clinical and echocardiographic features may carry diverse information about the development of heart failure (HF). Therefore, we determined heterogeneity in clinical and echocardiographic phenotypes and its association with exercise capacity. M ...
Full textLink to itemCite
Journal articleCirc Cardiovasc Imaging · November 2023
Infiltrative cardiomyopathies comprise a broad spectrum of inherited or acquired conditions caused by deposition of abnormal substances within the myocardium. Increased wall thickness, inflammation, microvascular dysfunction, and fibrosis are the common pa ...
Full textLink to itemCite
Journal articleJ Card Fail · June 2023
BACKGROUND: We sought to determine whether circulating modifiers of endothelial function are associated with cardiac structure and clinical outcomes in patients with heart failure with reduced ejection fraction (HFrEF). METHODS: We measured 25 proteins rel ...
Full textLink to itemCite
Journal articleCirc Cardiovasc Imaging · May 2023
BACKGROUND: The relationship between body size and cardiovascular events is complex. This study utilized the ADVANCE (Assessing Diagnostic Value of Noninvasive FFRCT in Coronary Care) Registry to investigate the association between body mass index (BMI), c ...
Full textLink to itemCite
Journal articleJ Thorac Imaging · January 1, 2023
Prospective head-to-head comparison of coronary calcium scores between standard computed tomography (CT) and photon-counting CT show no significant differences, while photon-counting CT administers substantially lower radiation dose. ...
Full textLink to itemCite
Journal articleFront Cardiovasc Med · 2023
Hypertensive disorders of pregnancy (HDP) are rising in prevalence and associated with adverse maternal and infant health outcomes. Current guidelines recommend labetalol, nifedipine, and methyldopa as acceptable first-line agents to treat HDP in outpatien ...
Full textLink to itemCite
Journal articleJAMA Cardiol · September 1, 2022
IMPORTANCE: In patients with severe aortic stenosis and left ventricular ejection fraction (LVEF) less than 50%, early LVEF improvement after transcatheter aortic valve replacement (TAVR) is associated with improved 1-year mortality; however, its associati ...
Full textLink to itemCite
Journal articleJACC Cardiovasc Imaging · September 2022
Coronary artery calcium (CAC) is a specific marker of coronary atherosclerosis that can be used to measure calcified subclinical atherosclerotic burden. The Agatston method is the most widely used scoring algorithm for quantifying CAC and is expressed as t ...
Full textLink to itemCite
Journal articleProg Cardiovasc Dis · 2022
BACKGROUND: The GUIDE-IT trial was, a multicenter, randomized, parallel group, unblinded study that randomized patients to having heart failure therapy titrated to achieve an NT-proBNP <1000 pg/mL or to usual clinical care. METHODS AND RESULTS: We performe ...
Full textLink to itemCite
Journal articleJ Cardiovasc Comput Tomogr · 2022
BACKGROUND: Coronary artery calcium (CAC) and left ventricular diastolic dysfunction (LVDD) are strong predictors of cardiovascular events and share common risk factors. However, their independent association remains unclear. METHODS: In the Project Baseli ...
Full textLink to itemCite
Journal articleExpert Opin Drug Metab Toxicol · November 2021
INTRODUCTION: Hypertensive disorders of pregnancy (HDP) are rising in prevalence, and increase risk of adverse maternal and fetal outcomes. Physiologic changes occur during pregnancy that alter drug pharmacokinetics. However, antihypertensive drugs lack pr ...
Full textLink to itemCite
Journal articleJ Am Heart Assoc · May 18, 2021
Background NT-proBNP (N-terminal pro-B-type natriuretic peptide) is a prognostic biomarker in heart failure (HF) with reduced ejection fraction. However, it is unclear whether there is a sex difference in NT-proBNP response and whether the therapeutic goal ...
Full textLink to itemCite
Journal articleJ Cardiovasc Comput Tomogr · 2021
BACKGROUND: Left ventricular assist devices (LVAD) are increasingly used for durable mechanical circulatory support in advanced heart failure. While LVAD therapy provides substantial improvement in mortality and quality of life, long-term therapy confers i ...
Full textLink to itemCite
Journal articleBr J Radiol · January 1, 2021
Cardiovascular imaging has significantly evolved since the turn of the century. Progress in the last two decades has been marked by advances in every modality used to image the heart, including echocardiography, cardiac magnetic resonance, cardiac CT and n ...
Full textLink to itemCite
Journal articleJ Med Imaging (Bellingham) · January 2021
Purpose: Quantifying stenosis in cardiac computed tomography angiography (CTA) images remains a difficult task, as image noise and cardiac motion can degrade image quality and distort underlying anatomic information. The purpose of this study was to develo ...
Full textLink to itemCite
Journal articleJACC Cardiovasc Interv · June 8, 2020
OBJECTIVES: This study sought to evaluate the association between severity of left ventricular hypertrophy (LVH) before transcatheter aortic valve replacement (TAVR) and outcomes out to 5 years. BACKGROUND: Prior studies assessing the association between b ...
Full textLink to itemCite
Journal articleJ Am Coll Cardiol · May 19, 2020
BACKGROUND: Greater early left ventricular mass index (LVMi) regression is associated with fewer hospitalizations 1 year after transcatheter aortic valve replacement (TAVR). The association between LVMi regression and longer-term post-TAVR outcomes is uncl ...
Full textLink to itemCite
Journal articleAm Heart J · May 2020
BACKGROUND: The evolution and clinical impact of cardiac remodeling after large ST-elevation myocardial infarction (STEMI) is not well delineated in the current therapeutic era. METHODS: The PRESERVATION I trial longitudinally assessed cardiac structure an ...
Full textLink to itemCite
Journal articleJAMA Intern Med · April 1, 2020
IMPORTANCE: Patients with abnormal (positive) exercise electrocardiography, but normal stress echocardiography (+ECG/-Echo) are commonly encountered in clinical practice; however, the prognostic significance of this discordant result is unclear. OBJECTIVE: ...
Full textLink to itemCite
Journal articleJACC Heart Fail · March 2019
The incidence of heart failure (HF) is increasing, particularly among women, and constitutes a rapidly growing public health problem. The primary prevention of HF in women should involve targeted, sex-specific strategies to increase awareness, promote a he ...
Full textLink to itemCite
Journal articleAm Heart J · February 2019
BACKGROUND: Although sex differences exist in the management of acute coronary syndromes, less is known about the management and outcomes of women and men with suspected coronary artery disease being evaluated with noninvasive testing (NIT). METHODS: We in ...
Full textLink to itemCite
Journal articleJACC Heart Fail · February 2019
OBJECTIVES: This study aims to assess the association between biomarker-guided therapy and left ventricular (LV) remodeling. BACKGROUND: In patients with heart failure with reduced ejection fraction (HFrEF), it is unclear if lowering natriuretic peptides r ...
Full textLink to itemCite
Journal articleEur J Radiol · November 2018
PURPOSE: To assess the impact of computed tomography-derived fractional flow reserve (FFRCT) on reader confidence and reader time for interpretation of coronary computed tomography angiography (CCTA). MATERIAL AND METHODS: This IRB-approved, HIPAA-complian ...
Full textLink to itemCite
Journal articleAm Heart J · July 2018
BACKGROUND: Sleep-disordered breathing (SDB), including central and obstructive sleep apnea, is a marker of poor prognosis in heart failure (HF) and may worsen cardiac dysfunction over time. Treatment of SDB with adaptive servoventilation (ASV) may reverse ...
Full textLink to itemCite
Journal articleJACC Cardiovasc Imaging · April 2018
OBJECTIVES: This study sought to determine whether mobile health (mHealth) device assessments used as clinical decision support tools at the point-of-care can reduce the time to treatment and improve long-term outcomes among patients with rheumatic and str ...
Full textLink to itemCite
Journal articleCirc Heart Fail · December 2017
BACKGROUND: Mitochondrial dysfunction and energy depletion in the failing heart are innovative therapeutic targets in heart failure management. Elamipretide is a novel tetrapeptide that increases mitochondrial energy; however, its safety, tolerability, and ...
Full textLink to itemCite
Journal articleJACC Cardiovasc Imaging · December 8, 2016
OBJECTIVES: The aim of this study was to evaluate the long-term performance of transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) through longitudinal echocardiographic analysis. BACKGROUND: The long-term performance ...
Full textLink to itemCite
Journal articleStat Methods Med Res · December 2016
Clinical core laboratories, such as Echocardiography core laboratories, are increasingly used in clinical studies with imaging outcomes as primary, secondary, or surrogate endpoints. While many factors contribute to the quality of measurements of imaging v ...
Full textLink to itemCite
Journal articleJ Am Soc Echocardiogr · December 2016
BACKGROUND: There is no broadly accepted standard method for assessing the quality of echocardiographic measurements in clinical research reports, despite the recognized importance of this information in assessing the quality of study results. METHODS: Twe ...
Full textOpen AccessLink to itemCite
Journal articleJ Am Coll Cardiol · June 7, 2016
BACKGROUND: Although risk stratification is an important goal of cardiac noninvasive tests (NITs), few contemporary data exist on the prognostic value of different NITs according to patient sex. OBJECTIVES: The goal of this study was to compare the results ...
Full textLink to itemCite
Journal articleJACC Cardiovasc Imaging · April 2016
OBJECTIVES: The aim of this study was to determine whether presentation, risk assessment, testing choices, and results differ by sex in stable symptomatic outpatients with suspected coronary artery disease (CAD). BACKGROUND: Although established CAD presen ...
Full textLink to itemCite
Journal articleAm Heart J · September 2015
BACKGROUND: Therapies that reverse pathologic left ventricular (LV) remodeling are often associated with improved outcomes. The incidence and impact of reverse LV remodeling after high-risk percutaneous coronary intervention (PCI) are unknown. METHODS: The ...
Full textLink to itemCite
Journal articleJ Am Soc Echocardiogr · August 2015
BACKGROUND: Interpretative variability can adversely affect echocardiographic reliability, but there is no widely accepted method to minimize variability and improve reproducibility. METHODS: A continuous quality improvement process was devised that involv ...
Full textLink to itemCite
Journal articleHeart International · January 1, 2013
Coronary computed tomography angiography (CCTA) is increasingly used for the assessment of coronary heart disease (CHD) in symptomatic patients. Software applications have recently been developed to facilitate efficient and accurate analysis of CCTA. This ...
Full textCite
Journal articleAm J Emerg Med · November 2012
OBJECTIVE: We describe our preliminary experience with coronary computed tomography angiography (CCTA) in emergency department (ED) patients with low- to intermediate-risk chest pain. METHODS: A convenience cohort of patients with low- to intermediate-risk ...
Full textLink to itemCite
Journal articleRadiol Clin North Am · September 2011
Congenital thoracic vascular anomalies include embryologic developmental disorders of the thoracic aorta, aortic arch branch arteries, pulmonary arteries, thoracic systemic veins, and pulmonary veins. Diagnostic evaluation of these anomalies in pediatric p ...
Full textLink to itemCite
Journal articleVasc Health Risk Manag · September 7, 2010
Myocardial infarction (MI) is defined by the presence of myocardial necrosis in combination with clinical evidence of myocardial ischemia. Cardiac troponins are regulatory proteins within the myocardium that are released into the circulation when damage to ...
Full textLink to itemCite